دسترسی عمومی

Cord-blood engraftment with ex vivo mesenchymal-cell coculture‏

M De Lima, I McNiece, SN Robinson, M Munsell, M Eapen, M Horowitz, ...‏

New England Journal of Medicine 367 (24), 2305-2315, 2012‏

تعهدات: US National Institutes of Health‏

Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure‏

M Duval, JP Klein, W He, JY Cahn, M Cairo, BM Camitta, R Kamble, ...‏

Journal of clinical oncology 28 (23), 3730-3738, 2010‏

تعهدات: US National Institutes of Health‏

[PDF] wiley.com

Maintenance therapy with low‐dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome: a …‏

M De Lima, S Giralt, PF Thall, L de Padua Silva, RB Jones, K Komanduri, ...‏

Cancer 116 (23), 5420-5431, 2010‏

تعهدات: US National Institutes of Health‏

Survival of patients with acute myeloid leukemia relapsing after allogeneic hematopoietic cell transplantation: a center for international blood and marrow transplant research …‏

N Bejanyan, DJ Weisdorf, BR Logan, HL Wang, SM Devine, M de Lima, ...‏

Biology of Blood and Marrow Transplantation 21 (3), 454-459, 2015‏

تعهدات: US National Institutes of Health‏

Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial‏

M De Lima, J McMannis, A Gee, K Komanduri, D Couriel, BS Andersson, ...‏

Bone marrow transplantation 41 (9), 771-778, 2008‏

تعهدات: US National Institutes of Health‏

High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation‏

SO Ciurea, M De Lima, P Cano, M Korbling, S Giralt, EJ Shpall, X Wang, ...‏

Transplantation 88 (8), 1019-1024, 2009‏

تعهدات: US National Institutes of Health‏

Improved early outcomes using a T cell replete graft compared with T cell depleted haploidentical hematopoietic stem cell transplantation‏

SO Ciurea, V Mulanovich, RM Saliba, UD Bayraktar, Y Jiang, R Bassett, ...‏

Biology of Blood and Marrow Transplantation 18 (12), 1835-1844, 2012‏

تعهدات: US National Institutes of Health‏

Multi-institutional study of post-transplantation cyclophosphamide as single-agent graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation using …‏

CG Kanakry, PV O'Donnell, T Furlong, MJ De Lima, W Wei, M Medeot, ...‏

Journal of Clinical Oncology 32 (31), 3497-3505, 2014‏

تعهدات: US National Institutes of Health‏

Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigen–matched unrelated and …‏

A Di Stasi, DR Milton, LM Poon, A Hamdi, G Rondon, J Chen, SR Pingali, ...‏

Biology of Blood and Marrow Transplantation 20 (12), 1975-1981, 2014‏

تعهدات: US National Institutes of Health‏

Reduced-intensity transplantation for lymphomas using haploidentical related donors versus HLA-matched sibling donors: a Center for International Blood and Marrow Transplant …‏

N Ghosh, R Karmali, V Rocha, KW Ahn, A DiGilio, PN Hari, V Bachanova, ...‏

Journal of Clinical Oncology 34 (26), 3141-3149, 2016‏

تعهدات: US National Institutes of Health‏

[PDF] wiley.com

Low‐dose azacitidine after allogeneic stem cell transplantation for acute leukemia‏

E Jabbour, S Giralt, H Kantarjian, G Garcia‐Manero, M Jagasia, ...‏

Cancer 115 (9), 1899-1905, 2009‏

تعهدات: US National Institutes of Health‏

Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia‏

MR Litzow, S Tarima, WS Pérez, BJ Bolwell, MS Cairo, BM Camitta, ...‏

Blood, The Journal of the American Society of Hematology 115 (9), 1850-1857, 2010‏

تعهدات: US National Institutes of Health‏

Once daily iv busulfan and fludarabine (iv Bu-Flu) compares favorably with iv busulfan and cyclophosphamide (iv BuCy2) as pretransplant conditioning therapy in AML/MDS‏

BS Andersson, M de Lima, PF Thall, X Wang, D Couriel, M Korbling, ...‏

Biology of Blood and Marrow Transplantation 14 (6), 672-684, 2008‏

تعهدات: US National Institutes of Health‏

Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myeloma‏

U Popat, R Saliba, R Thandi, C Hosing, M Qazilbash, P Anderlini, ...‏

Biology of Blood and Marrow Transplantation 15 (6), 718-723, 2009‏

تعهدات: US National Institutes of Health‏